UNSPSC 51123708: Bunaftine hydrochloride

This classification denotes an antiarrhythmic agent with the molecular formula C21H30N2O.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YH47NU604H. European Medicines Agency schedules bunaftine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00897MIG. Most nations, for tariff and trade purposes, schedule bunaftine hydrochloride under HS 29242995 and SITC 51479. As of Q4 2014, BUNAFTINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

SMILES: CCCCN(CCN(CC)CC)C(=O)C1CCCC2C1CCCC2.CL.

UNSPSC 51123708 Bunaftine hydrochloride is a Commodity code covering specialty pharmaceuticals and injectable medications procured by state and local health systems, emergency services, and pharmacy benefit programs. State and local governments purchase under this code primarily to support emergency medical services, hospital formularies, and state health agency pharmacy programs. Recent solicitations show demand for advanced life support medications, generic pharmaceuticals, and specialty injectables distributed through authorized wholesale channels to public health facilities and emergency responders.

Issuing bodies include city fire and rescue services, state health agencies, and multistate cooperative purchasing alliances. The City of Tampa Fire Rescue and the Texas Health and Human Services Commission represent recent buyers; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administered by the Minnesota Department of Administration also actively solicits under related pharmaceutical codes on behalf of participating state and local members. Recent activity spans Florida, Texas, Minnesota, and Oregon. The City of Tampa issued IFB 26P00188 for Advanced Life Support Medications with a due date of April 8, 2026, requesting 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials for Tampa Fire Rescue with an estimated contract value of $40,000.00 and a one-year term plus options for two additional one-year renewals; this solicitation included a Small Local Business Enterprise sheltered market designation with a 5 percent bid discount capped at $10,000. MMCAP issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, requiring vendor certification of compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, with an effective date of July 1, 2026, and a two-year contract term.